Genelabs Technologies

Genelabs Technologies, Inc. is a biopharmaceutical company dedicated to the discovery and development of treatments for infectious diseases to improve human health. The company's pipeline includes infectious disease programs focused on hepatitis C virus infection and late-stage clinical assets.